SEOUL, Aug. 16 (Korea Bizwire) — Major South Korean pharmaceutical companies expanded their spending on research and development (R&D) during the first half this year, with Hanmi Pharmaceutical Co. allocating the most, industry data showed Wednesday. According to their semi-annual business reports, 10 out of the 15 drug companies spent more on R&D during the [...]
SEOUL, Jan. 21 (Korea Bizwire) – South Korea’s major pharmaceutical companies are poised to sharply expand their spending on research and development (R&D) in 2016, taking a page from Hanmi Pharmaceutical Co.’s aggressive investment that has led to a series of mega-hit licensing deals, industry sources said Thursday. Of the country’s top 10 drug companies [...]
SEOUL, Nov. 14 (Korea Bizwire) – South Korea was the world’s most research and development intensive country in 2012, spending 4.36 percent of GDP on R&D, according to the OECD Science, Technology and Industry Outlook 2014. Korea also was the top at the R&D spending rate out of the total revenue, representing 3.4 percent. The report [...]